Ken Griffin Nls Pharmaceutics Ltd. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 19,183 shares of NLSP stock, worth $3,836. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,183Holding current value
$3,836% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NLSP
# of Institutions
9Shares Held
8.16MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$1.15 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.17MShares$434,4000.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny180KShares$35,9150.0% of portfolio
-
Xtx Topco LTD London, X025.6KShares$5,1180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA14.4KShares$2,8720.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $5.87M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...